Assessing microvessels and angiogenesis in human breast cancer, using VE-cadherin

Histopathology

Volumn 46, Issue 4, 2005, Pages 422-430

  Martin, Tracey A ^a   Watkins, G ^a   Lane, J ^a   Jiang, W G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Angiogenic marker; Breast cancer; VE cadherin

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8; CADHERIN; CADHERIN VE; CD31 ANTIGEN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; BREAST CANCER; BREAST DUCT; DISEASE COURSE; FROZEN SECTION; HUMAN; HUMAN TISSUE; MICROVASCULATURE; NOTTINGHAM PROGNOSTIC INDEX; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TUMOR VASCULARIZATION;

ANTIGENS, CD; ANTIGENS, CD31; BLOOD VESSELS; BREAST NEOPLASMS; CADHERINS; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBOPLASTIN;

EID: 17144422869     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02104.x     Document Type: Article

References (35)

1. Folkman J. Angiogenesis-retrospect and outlook. EXS 1992; 61; 4-13.
2. Bicknell R, Harris AL. Mechanisms and therapeutic implications of angiogenesis. Curr. Opin. Oncol. 1996; 8; 60-65.
3. Pluda JM. Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies. Semin. Oncol. 1997; 24; 203-218.
4. Gerson R, Serrano A, Villalobos A et al. Biomarkers in the prognosis and treatment response of breast cancer. Gac. Med. Mex. 2002; 138; 15-24.
5. Prall F, Gringmuth U, Nizze H, Barten M. Microvessel densities and microvascular architecture in colorectal carcinomas and their liver metastases: significant correlation of high microvessel densities with better survival. Histopathology 2003; 42; 482-491.
6. Chalkley HW. Method for the quantitative morphologic analysis of tissues. J. Natl Cancer Inst. 1943; 4; 47-53.
7. Vermeulen PB, Gasparini G, Fox SB et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur. J. Cancer 1996; 32A; 2474-2484.
8. Vermeulen PB, Fox SB, Dirix LY, Colpaert C, Van Marck EA. Heterogeneity of vascularisation in invasive breast carcinoma. Eur. J. Cancer 2002; 38; 1951-1952.
9. Paradiso A, Ranieri G, Silvestris N et al. Failure of primary breast cancer neoangiogenesis to predict pattern of distant metastasis. Clin. Exp. Med. 2001; 1; 127-132.
10. Ding S, Merkulova-Rainon T, Han ZC, Tobelem G. HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. Blood 2003; 101; 4816-4822.
11. Cao G, O'Brien CD, Zhou Z et al. Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am. J. Physiol. Cell Physiol. 2002; 282; C1181-C1190.
12. Lampugnani MG, Resnati M, Raiteri M et al. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J. Cell Biol. 1992; 118; 1511-1522.
13. Lampugnani MG, Corada M, Caveda L et al. The molecular organization of endothelial cell to cell junctions. Differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J. Cell Biol. 1995; 129; 203-217.
14. Martin TA, Mansel R, Jiang WG. Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endothelial cells. Clin. Cancer Res. 2001; 7; 734-737.
15. Breviario F, Caveda L, Corada M et al. Functional properties of human vascular endothelial cadherin (7B4/ cadherin-5), an endothelium-specific cadherin. Arterioscler. Thromb. Vasc. Biol. 1995; 15; 1229-1239.
16. Lampugnani MG, Dejana E. Interendothelial junctions: structure, signalling and functional roles. Curr. Opin. Cell Biol. 1997; 9; 674-682.
17. Shih SC, Robinson GS, Perruzzi CA et al. Molecular profiling of angiogenesis markers. Am. J. Pathol. 2002; 161; 35-41.
18. Vailhe B, Kapp M, Dietl J, Arck P. Human first-trimester decidua vascular density: an immunohistochemical study using VE-cadherin and endoglin as endothelial cell markers. Am. J. Reprod. Immunol. 2000; 44; 9-15.
19. Jiang WG, Douglas-Jones A, Mansel RE. Level of expression of PPAR-gamma and its co-activator (PPAR-GCA) in human breast cancer. Int. J. Cancer 2003; 106; 752-757.
20. Jiang WG, Watkins G, Lane J et al. Prognostic value of Rho familty and rho-GDIs in breast cancer. Clin. Cancer Res. 2003; 9; 6432-6440.
21. Martin TA, Matsumot K, Nakamura T, Mansel RE, Jiang WG. NK4 reduced HGF/ SF and fibroblast induced breast tumour growth. Carcinogenesis 2003; 24; 1317-1325.
22. Buerger H, Mommers EC, Littmann R et al. Correlation of morphologic and cytogenetic parameters of genetic instability with chromosomal alterations in in situ carcinomas of the breast. Am. J. Clin. Pathol. 2000; 114; 854-859.
23. Roylance R, German P, Harris W et al. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res. 1999; 59; 1433-1436.
24. Jahroudi N, Lynch DC. Endothelial-cell-specific regulation of von Willebrand factor gene expression. Mol. Cell. Biol. 1994; 14; 999-1008.
25. Aird WC, Jahroudi N, Weiler-Guettler H, Rayburn HB, Rosenberg RD. Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc. Natl Acad. Sci. USA 1995; 92; 4567-4571.
26. Teo NB, Shoker BS, Jarvis C, Martin L, Sloane JP, Holcombe C. Angiogenesis and invasive recurrence in ductal carcinoma in situ of the breast. Eur. J. Cancer 2003; 39; 38-44.
27. Albeda FW, van der Meer J, Vellenga E. Vascular proliferation as an unusual cause of hemorrhagic diathesis in myelofibrosis. Am. J. Clin. Pathol. 1991; 95; 564-566.
28. McKenney JK, Weiss SW, Folpe AL. CD31 expression in intratumoral macrophages: a potential diagnostic pitfall. Am. J. Surg. Pathol 2001; 25; 1167-1173.
29. Salven P, Joensuu H, Heikkila P et al. Endothelial Tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis. Br. J. Cancer 1996; 74; 69-72.
30. Goulding H, Abdul Rashid NF, Robertson JF et al. Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum. Pathol. 1995; 26; 1196-1200.
31. Yuan A, Yang PC, Yu CJ et al. Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer. Am. J. Respir. Crit. Care Med. 1995; 152; 2157-2162.
32. Nawroth R, Poell G, Ranft A et al. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J. 2002; 21; 4885-4895.
33. Halama T, Staffler G, Hoch S, Stockinger H, Wolff K, Petzelbauer P. Vascular-endothelial cadherin (CD144)- but not PECAM-1 (CD31)-based cell-to-cell contacts convey the maintenance of a quiescent endothelial monolayer. Int. Arch. Allergy Immunol. 1999; 120; 237-244.
34. Vitolo D, Paradiso P, Uccini S, Ruco LP, Baroni CD. Expression of adhesion molecules and extracellular matrix proteins in glioblastomas: relation to angiogenesis and spread. Histopathology 1996; 28; 521-528.
35. Horak ER, Leek R, Klenk N et al. Angiogenesis, assessed by platelet/ endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992; 340; 1120-1124.